TrivarX Limited is a health technology company specializing in developing artificial intelligence-driven devices and software for the objective screening, diagnosis, and management of behavioral health conditions, particularly depression and other mental health disorders. Through robust clinical research, TrivarX has created proprietary algorithms capable of spectral analysis of sleep patterns and heart rate variability, facilitating early and accurate identification of mental illness from electrical signals in the brain and heart. The company’s lead products offer scientifically validated solutions for both healthcare providers and corporate wellness initiatives, aiming to improve mental health outcomes using data-driven methodologies. Operating within the Health Information Services industry, TrivarX serves the broader healthcare sector and contributes to the growing intersection of digital technology and behavioral health sciences. TrivarX’s innovations have market significance by supporting mental health screening and monitoring with evidence-based tools, meeting the increasing demand for scalable, objective measures in mental health diagnostics and management.